CPT code 20975 identifies the surgical implantation of an electrical bone growth stimulation device placed at a fracture site to promote bone healing. The procedure represents an important adjunctive option in orthopedic care for fractures at risk of delayed union or nonunion and has implications for hospital and ambulatory surgery workflows, device utilization, and coverage policy nationally. Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical purpose of the code, typical sites of service, and how major payers approach coverage for implanted electrical bone stimulators. The publication summarizes benchmark utilization metrics, common billing and coding considerations, and recent policy developments affecting coverage and reimbursement for surgically implanted bone stimulation devices. It also provides clinical context regarding indications for use and where the service fits among other fracture-healing interventions. Data not available in the input is noted where applicable, and the analysis is presented for a national audience without state-specific variation.